4.2.2000 Official Journal of the European Communities L 30/35 COMMISSION DECISION of 17 December 1999 for the purchase by the Community of foot-and-mouth disease antigens and for the formulation, production, bottling and distribution of vaccines against foot-and-mouth disease (notified under document number C(1999) 4683) (2000/77EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (*), as last amended by Regulation (EC) No 1258/1999 (%), and in particular Article 14 thereof, Having regard to Council Decision 91/666/EEC of 11 December 1991  establishing Community reserves —of foot-and-mouth disease vaccines (’), as last amended by Council Decision 1999/762/EC (%), and in particular Article 5 thereof, Whereas: (1) In conformity with Decision 91/666/EEC, the purchase of antigens is a part of the Community action to establish Community reserves of foot-and-mouth disease vaccines. (2) By Commission Decision 93/590/EC of 5 November 1993 for the purchase by the Community of foot-and-mouth disease antigens within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines (°), as last amended by Decision 95/471/EC (%), arrangements were made for purchase of A5, A22 and O1 foot-and-mouth disease antigen. (3) By Commission Decision 97/348/EC of 23 May 1997 for the purchase by the Community of foot-and-mouth disease antigens and for the formulation, production, bottling and  distribution  of  vaccines  against foot-and-mouth disease (7), arrangements were made for purchase of A22 Irag, C1 and ASIA1 foot-and-mouth disease antigen. (4) Owing to the disease situation, additional antigens are required. () OJ L 224, 18.8.1990, p. 19. () OJ L 160, 26.6.1999, p. 103. () OJ L 368, 31.12.1991, p. 21. () OJ L 301, 24.11.1999, p. 6. () OJ L 280, 13.11.1993, p. 33. (®) OJ L 269, 11.11.1995, p. 29. () (5) The measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee, HAS ADOPTED THIS DECISION: Article 1 1.  The Community shall purchase as soon as possible the following strains of foot-and-mouth disease antigen: — A lIran 96: 1 000 000 doses, — A lIran 99: 1 000 000 doses, — A Malaysia 97: 500 000 doses, — SAT1: 500 000 doses, — SAT?2 (Southern Africa): 500 000 doses, — SAT?2 (East Africa): 500 000 doses, — SAT3: 500 000 doses. 2. The Community shall make arrangements for formulation, production, bottling and distribution of vaccines against foot-and-mouth disease produced from antigens referred to in paragraph 1. 3. The maximum cost of the measures referred to in paragraphs 1 and 2 shall be up to EUR 2,5 million. 4. The action referred to in paragraph 3 shall be organised by the Commission before 31 December 1999. Article 2 The measures mentioned in Article 1(3) shall be carried out by the Commission in cooperation with the supplier designated by call for tender.